Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Birch

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Brain Research|February 4, 1998
Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cordM R Young, S M Fleetwood-Walker, T Dickinson, et al.
Brain Research|December 16, 1996
Neuropeptide changes persist in spinal cord despite resolving hyperalgesia in a rat model of mononeuropathyR Munglani, S M Harrison, G D Smith, et al.
Pain|October 1, 1995
Changes in neuronal markers in a mononeuropathic rat model relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesiaR Munglani, A Bond, G D Smith, et al.
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
British Journal of Pharmacology|July 1, 1991
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonistP J Birch, H Rogers, A G Hayes, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
British Journal of Pharmacology|August 1, 1992
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activityH Rogers, P J Birch, S M Harrison, et al.
Journal of Medicinal Chemistry|January 1, 1992
Synthesis, antinociceptive activity, and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenolsD B Judd, D S Brown, J E Lloyd, et al.
British Journal of Pharmacology|December 1, 1990
A series of novel, highly potent and selective agonists for the kappa-opioid receptorA G Hayes, P J Birch, N J Hayward, et al.
British Journal of Pharmacology|December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonistD T Beattie, I J Beresford, H E Connor, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Brain Research|February 4, 1998
Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cordM R Young, S M Fleetwood-Walker, T Dickinson, et al.
Brain Research|December 16, 1996
Neuropeptide changes persist in spinal cord despite resolving hyperalgesia in a rat model of mononeuropathyR Munglani, S M Harrison, G D Smith, et al.
Pain|October 1, 1995
Changes in neuronal markers in a mononeuropathic rat model relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesiaR Munglani, A Bond, G D Smith, et al.
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
British Journal of Pharmacology|July 1, 1991
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonistP J Birch, H Rogers, A G Hayes, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
British Journal of Pharmacology|August 1, 1992
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activityH Rogers, P J Birch, S M Harrison, et al.
Journal of Medicinal Chemistry|January 1, 1992
Synthesis, antinociceptive activity, and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenolsD B Judd, D S Brown, J E Lloyd, et al.
British Journal of Pharmacology|December 1, 1990
A series of novel, highly potent and selective agonists for the kappa-opioid receptorA G Hayes, P J Birch, N J Hayward, et al.
British Journal of Pharmacology|December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonistD T Beattie, I J Beresford, H E Connor, et al.
Pageof 5